Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Inventory Turnover Ratio 2010-2023 | CPHI

China Pharma Holdings inventory turnover ratio from 2010 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
  
China Pharma Holdings Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.675B 5.30
Dr Reddy's Laboratories (RDY) India $11.950B 18.89
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.438B 0.00
Bausch Health Cos (BHC) Canada $3.194B 2.49
Amphastar Pharmaceuticals (AMPH) United States $1.999B 13.68
Supernus Pharmaceuticals (SUPN) United States $1.611B 0.00
Taysha Gene Therapies (TSHA) United States $0.482B 0.00
Generation Bio (GBIO) United States $0.208B 0.00
Assembly Biosciences (ASMB) United States $0.080B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00